Global Amphotericin B Market – Industry Trends and Forecast to 2030

Global Amphotericin B Market, By Product Type (Static Drops, Atomization Inhalation, Local Lesion Injection, Other), Application (Vaginitis, Candida Infection, Leishmaniasis, Kala-Azar, Cryptococcal Infection, Aspergillus Infection, Other), Route of Administration (Intravenous, Parenteral, Oral, Other), Drug Class (Antifungals, Systemic, Other), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.

Amphotericin B Market Analysis and Size

Rise in the prevalence of fungal infections, emerging markets, rise in healthcare expenditure and growing government funds and initiatives for spreading awareness are the factors that will expand the global amphotericin B market. Rising R&D activities and clinical trials will provide beneficial opportunities for the global amphotericin B market in the forecast period of 2023-2030. Rise in the population that possess antifungal drug resistance and side effects of Amphotericin B such as blue lips, seizures, abdominal pain, numbness, fever, and other common effects are the factors that will hamper the market growth and will further challenge the global amphotericin B market in the forecast period.

Data Bridge Market Research analyzes that the global amphotericin b market which was USD 0.22 billion in 2022, would rocket up to USD 0.30  billion by 2030, and is expected to undergo a CAGR of 4.6% during the forecast period 2023 to 2030. This indicates the market value. “static drops” dominates the product segment of the global amphotericin b market owing to the increasing number of fungal diseases. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Amphotericin B Market Scope and Segmentation

Market Definition

Amphotericin B is a polyene antifungal antibiotic which is produced by Streptomyces nodosus. It is used for the treatment of fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis. It acts by stopping the growth of fungi as it binds to ergosterol (an important component of fungal membrane). It further causes depolarization of the membrane and altering cell membrane permeability which leads to leakage of important intracellular components, cell rupture, and results in cell death. It is given by injection into a vein.

Amphotericin B Market Dynamics

Drivers

• Increase in cases of hospital acquired infection

Hospital-acquired infections (HAIs) can indeed contribute to an increase in the demand for medications such as Amphotericin B, which is an antifungal medication. HAIs are infections that patients acquire during their stay in a healthcare facility, including hospitals, clinics, and long-term care facilities. These infections can be caused by bacteria, viruses, fungi, or other pathogens, and they pose a significant challenge to patient care and overall healthcare systems.

•  Increase in demand for effective antifungal drugs

Fungal infections have been on the rise globally, affecting various populations, including immunocompromised individuals, patients with chronic diseases, and those undergoing invasive medical procedures. Factors such as the aging population, increased use of immunosuppressive therapies, and the spread of drug-resistant fungal strains contribute to the growing incidence of fungal infections.

Opportunities

Growing unhygienic practices

Unhygienic practices and the presence of hospital-acquired infections are significant concerns for patient safety and public health. These practices can lead to increased rates of infections and pose serious risks to patients.    

Restraints/Challenges

High investment requirements

However, obstacles such as high investment requirements, high treatment costs, and expensive capital expenditure on equipment are expected to stymie market expansion, as are technical challenges with sample collection and a lack of suitable reimbursement.  

This global amphotericin b market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. To gain more info on the surgical microscopes market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In 2021, SP Accure Labs announced launching of amphotericin B emulsion. This drug is used in treatment of mucormycosis  
• In 2021, Celon Laboratories announced launching of amphotericin B emulsion. This drug can be used in treatment of mucormycosis commonly known as black fungus  
• In 2021, TLC a drug maker company announced the launch of liposomal amphotericin B in India. The product is named AmphoTLC and can be effective in the treatment of mucormycosis  

Global Amphotericin B Market Scope

The global amphotericin b market is segmented on the basis of product type, application, route of administration, drug class, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• STATIC DROPS,
• ATOMIZATION INHALATION,
• LOCAL LESION INJECTION,
• OTHER

Application

• VAGINITIS
• CANDIDA INFECTION
• LEISHMANIASIS
• KALA-AZAR
• CRYPTOCOCCAL INFECTION
• ASPERGILLUS INFECTION
• OTHER

Route Of Administration

• INTRAVENOUS
•  PARENTERAL
• ORAL
• OTHERS

Drug Class

• ANTIFUNGALS
• SYSTEMIC
• OTHER

End User

• CLINIC
• HOSPITAL
• OTHERS

Distribution Channel

• HOSPITAL PHARMACY
• RETAIL PHARMACY
• ONLINE PHARMACY

Global Amphotericin B Market Regional Analysis/Insights

The global amphotericin b market is analyzed and market size insights and trends are provided by country, product type, application, route of administration, drug class, end-users, and distribution channel as referenced above. 

The countries covered in the global amphotericin b market  report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America dominates the global amphotericin b market because of the increasing healthcare initiatives, the strong presence of major players in the market, increasing cases of chronic fungal conditions and rising number of research activities in this region.    

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global amphotericin b market also provides you with detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global rare biomarkers market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the surgical microscopes market. The data is available for the historic period 2010-2020.

Competitive Landscape and Global Amphotericin B Market Share Analysis

The global amphotericin b market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the global amphotericin b market are:

• Bristol-Myers Squibb Company (US)
• MATINAS BIOPHARMA HOLDINGS, INC. (US)
• Nano-X Imaging LTD. (Israel)
• Nanomerics (UK)
• DNDi (Geneva)
• Abzena Ltd (UK)
• Bharat Serums and Vaccines Limited (BSV) (India)
• Astellas Pharma Inc.(Japan)
• Leadiant Biosciences (Italy), Inc.
• Lilly (US), InterMune (US)
• Jina Pharmaceuticals (US)
• SteriMax (India)
• XGen Pharmaceuticals DJB, Inc. (US)